Quantcast

Latest Stem cells Stories

2014-08-08 12:25:15

SAN DIEGO, Aug. 8, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, announced today that it has completed a private equity financing transaction, providing the Company with $5.4 million through the sale of Series C-1 Preferred Stock, together with warrants to purchase common stock. The first closing of the Series C-1 financing occurred in July 2013. This...

2014-08-08 11:20:47

Cell Transplantation Center of Excellence for Aging and Brain Repair Induced immunorejection may eliminate tumors post-cell transplantation Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation. In an...

2014-08-08 08:25:57

GERMANTOWN, Md., Aug. 8, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months and six months ended June 30, 2014 and provided a business and clinical update. "We are pleased to report that 2014 has already seen the company achieve several major milestones. In late July, we completed the last of the surgeries in the NSI-566/ALS Phase II trial. Each of the patients in the final cohort have received a total of 16 million NSI-566 neural...

2014-08-07 12:28:21

DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Regenerative Medicine Market in the US 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Regenerative Medicine market in the US has witnessed a number of mergers and acquisitions by leading vendors in the past few years. Vendors are focusing on mergers and acquisitions to strengthen their global position and increase their commercial capabilities. For...

2014-08-05 08:35:20

The company aims to increase the market penetration of its proprietary MSC-based research products, while expanding its stem cell segment to include differentiated cells derived from MSCs MOUNTAIN VIEW, Calif., Aug. 5, 2014 /PRNewswire/ -- Based on its recent analysis of the stem cell tools and technologies industry, Frost & Sullivan recognizes Vitro Biopharma with the 2014 North American Frost & Sullivan Award for Technology Innovation Leadership. Vitro Biopharma has excelled in the...

2014-08-04 08:29:33

GERMANTOWN, Md., Aug. 4, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The multicenter Phase II trial treated 15 ambulatory patients in five different dosing cohorts. The first 12 patients received injections in the cervical region of the spinal cord only, where the stem cells...

2014-07-31 23:21:06

The Adult Stem Cell Technology Center, LLC in Boston Massachusetts has more adult stem cell intellectual property than it requires for its own current business development plans. To get its additional adult stem cell technologies into greater practice, the company recently launched a social media marketing campaign. Boston, MA (PRWEB) July 31, 2014 Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) finds itself flush with innovative adult stem cell biotechnologies. Currently the...

2014-07-31 08:36:26

HONG KONG, July 31, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has filed with the U.S. Securities and Exchange Commission its Annual Report on Form 20-F, which included audited financial statements for the fiscal year ended March 31, 2014. The Form 20-F can be accessed by...

2014-07-28 23:05:32

Medical discoveries continue to reveal the many uses for which stem cell treatment can be used, ranging from kidney disease to brain damage. A recent case study conducted by Skinspirations demonstrated the healing results that stem cell treatment induces in patients with osteoarthritis. Tampa Bay, FL (PRWEB) July 28, 2014 Nearly 53 million Americans today are suffering with arthritis, with the majority of them diagnosed with osteoarthritis. (1) Osteoarthritis is a degeneration of joint...

2014-07-28 23:03:19

Transparency Market Research has announced the addition of the "Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html. (PRWEB) July 28, 2014 According to a new market research report published by Transparency Market Research "Regenerative Medicine (Bone and Joint) Market (By Technology - Stem...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.